Latest STE news

Top 3 Health Care Stocks That May Rocket Higher In September

Benzinga · Mon, 21 Sep 2026 06:01:08 -0400

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha · Tue, 15 Sep 2026 15:11:37 -0400

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research · Fri, 04 Sep 2026 12:36:03 -0400

Steris (STE) reported earnings 30 days ago. What's next for the stock?

STERIS to Present at the Morgan Stanley Healthcare Conference

GlobeNewsWire · Tue, 01 Sep 2026 16:30:00 -0400

Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

Zacks Investment Research · Fri, 21 Aug 2026 13:05:19 -0400

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

Zacks Investment Research · Thu, 20 Aug 2026 11:51:10 -0400

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

STERIS Q1 Earnings Call Highlights

MarketBeat · Sun, 09 Aug 2026 04:04:25 -0400

STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.

Market information is provided for research and visualization and is not investment advice.